Pharma News
How precision and personalized medicine private equity performed in the pharmaceutical industry in Q2 2023
In value terms, precision and personalized medicine-related deal activity decreased by % in Q2 2023 compared with the previous quarter’s total of and fell by 83% as compared to Q2 2022. Related deal volume remained flat in Q2 2023 versus the previous quarter.
For further understanding of GlobalData’s Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition, buy the report here.
Source link
#precision #personalized #medicine #private #equity #performed #pharmaceutical #industry